These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 19789217

  • 1. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.
    Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I.
    Mol Cancer Ther; 2009 Oct; 8(10):2821-32. PubMed ID: 19789217
    [Abstract] [Full Text] [Related]

  • 2. Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
    Ottewell PD, Lefley DV, Cross SS, Evans CA, Coleman RE, Holen I.
    Int J Cancer; 2010 Jan 15; 126(2):522-32. PubMed ID: 19621384
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I.
    Clin Cancer Res; 2008 Jul 15; 14(14):4658-66. PubMed ID: 18628481
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.
    Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I.
    J Natl Cancer Inst; 2008 Aug 20; 100(16):1167-78. PubMed ID: 18695136
    [Abstract] [Full Text] [Related]

  • 5. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
    Szafran AA, Folks K, Warram J, Chanda D, Wang D, Zinn KR.
    Cancer Biol Ther; 2009 Jun 20; 8(12):1109-16. PubMed ID: 19652526
    [Abstract] [Full Text] [Related]

  • 6. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
    Haider MT, Holen I, Dear TN, Hunter K, Brown HK.
    Bone; 2014 Sep 20; 66(100):240-50. PubMed ID: 24971713
    [Abstract] [Full Text] [Related]

  • 7. Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells.
    Jeong J, Lee KS, Choi YK, Oh YJ, Lee HD.
    J Korean Med Sci; 2011 Dec 20; 26(12):1569-75. PubMed ID: 22147993
    [Abstract] [Full Text] [Related]

  • 8. Macrophages as potential targets for zoledronic acid outside the skeleton-evidence from in vitro and in vivo models.
    Rogers TL, Wind N, Hughes R, Nutter F, Brown HK, Vasiliadou I, Ottewell PD, Holen I.
    Cell Oncol (Dordr); 2013 Dec 20; 36(6):505-14. PubMed ID: 24177992
    [Abstract] [Full Text] [Related]

  • 9. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H, Sohara Y, Moats RA, Nelson MD, Groshen SG, Ye W, Reynolds CP, DeClerck YA.
    Cancer Res; 2007 Oct 01; 67(19):9346-55. PubMed ID: 17909043
    [Abstract] [Full Text] [Related]

  • 10. Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.
    Mundy GR, Yoneda T, Hiraga T.
    Semin Oncol; 2001 Apr 01; 28(2 Suppl 6):35-44. PubMed ID: 11346863
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation.
    Yang C, Davis JL, Zeng R, Vora P, Su X, Collins LI, Vangveravong S, Mach RH, Piwnica-Worms D, Weilbaecher KN, Faccio R, Novack DV.
    Cancer Discov; 2013 Feb 01; 3(2):212-23. PubMed ID: 23269702
    [Abstract] [Full Text] [Related]

  • 12. Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.
    Duivenvoorden WC, Vukmirović-Popović S, Kalina M, Seidlitz E, Singh G.
    Br J Cancer; 2007 May 21; 96(10):1526-31. PubMed ID: 17437017
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
    Daubiné F, Le Gall C, Gasser J, Green J, Clézardin P.
    J Natl Cancer Inst; 2007 Feb 21; 99(4):322-30. PubMed ID: 17312309
    [Abstract] [Full Text] [Related]

  • 14. Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.
    Kopecka J, Porto S, Lusa S, Gazzano E, Salzano G, Pinzòn-Daza ML, Giordano A, Desiderio V, Ghigo D, De Rosa G, Caraglia M, Riganti C.
    Oncotarget; 2016 Apr 12; 7(15):20753-72. PubMed ID: 26980746
    [Abstract] [Full Text] [Related]

  • 15. Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.
    Ottewell PD, Wang N, Brown HK, Reeves KJ, Fowles CA, Croucher PI, Eaton CL, Holen I.
    Clin Cancer Res; 2014 Jun 01; 20(11):2922-32. PubMed ID: 24687923
    [Abstract] [Full Text] [Related]

  • 16. Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.
    Suominen MI, Rissanen JP, Käkönen R, Fagerlund KM, Alhoniemi E, Mumberg D, Ziegelbauer K, Halleen JM, Käkönen SM, Scholz A.
    J Natl Cancer Inst; 2013 Jun 19; 105(12):908-16. PubMed ID: 23682134
    [Abstract] [Full Text] [Related]

  • 17. Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro.
    Woodward JK, Neville-Webbe HL, Coleman RE, Holen I.
    Anticancer Drugs; 2005 Sep 19; 16(8):845-54. PubMed ID: 16096432
    [Abstract] [Full Text] [Related]

  • 18. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
    Hiraga T, Williams PJ, Mundy GR, Yoneda T.
    Cancer Res; 2001 Jun 01; 61(11):4418-24. PubMed ID: 11389070
    [Abstract] [Full Text] [Related]

  • 19. Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
    Clyburn RD, Reid P, Evans CA, Lefley DV, Holen I.
    Cancer Chemother Pharmacol; 2010 Apr 01; 65(5):969-78. PubMed ID: 19730863
    [Abstract] [Full Text] [Related]

  • 20. Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Yamada T, Muguruma H, Yano S, Ikuta K, Ogino H, Kakiuchi S, Hanibuchi M, Uehara H, Nishioka Y, Sone S.
    Mol Cancer Ther; 2009 Jan 01; 8(1):119-26. PubMed ID: 19139120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.